1Kerr BM, Thummel KE, Wurden CJ, et al. Human liver carbamazepine metabolism: role of CYP3A4 and CYP2C8 in 10, 11-epoxide formation. Biochem Pharmacol, 1994,47(11) : 1969.
2Lanchote VL, Bonato PS, Canlpos GM, et al. Factors influencing plasma concentrations of carbamazepine and CBZ-10,11-epoxide in epileptic children and adults. Ther Drug Morni, 1995,17(1) :47.
3Bernus I, Dickinson RG, Hooper WD, et al. Dose-dependent metabolism of carbamazepine in humans. Epilepsy Res, 1996, 24(3):163.
4Delgado-Iribarnegaray MF, Santo-Bueldga D, Garcia-Sanchez MJ,et al. Carbamazepine population pharmacokinetics in children:mixed-effect models. Ther Drug Monit, 1997,19(2) : 132.
